![Paul M. Ness](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul M. Ness
Directeur/Membre du Conseil chez
Hemanext, Inc.
Profil
Paul M.
Ness is currently the Director at Hemanext, Inc. since 2021.
He is also the Senior Director-Division of Transfusion Medicine at The Johns Hopkins University since 1979.
Previously, he worked as the Director at Northfield Laboratories, Inc. from 2002 to 2009.
He also served as the President at the American Association of Blood Banks.
Dr. Ness completed his undergraduate degree at the Massachusetts Institute of Technology and obtained a doctorate from New York University in 1971.
Postes actifs de Paul M. Ness
| Sociétés | Poste | Début |
|---|---|---|
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/1979 |
Hemanext, Inc.
 Hemanext, Inc. Medical SpecialtiesHealth Technology Develops anaerobic storage system that minimizes oxidative damage to red blood cells | Directeur/Membre du Conseil | 03/08/2021 |
Anciens postes connus de Paul M. Ness
| Sociétés | Poste | Fin |
|---|---|---|
Northfield Laboratories, Inc.
 Northfield Laboratories, Inc. BiotechnologyHealth Technology Develops oxygen-carrying red blood cell substitutes to treat critical blood loss | Directeur/Membre du Conseil | 10/11/2009 |
American Association of Blood Banks
 American Association of Blood Banks Miscellaneous Commercial ServicesCommercial Services Operates an association of blood and biotherapies | President | - |
Formation de Paul M. Ness
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
87
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Northfield Laboratories, Inc.
Northfield Laboratories, Inc. BiotechnologyHealth Technology Develops oxygen-carrying red blood cell substitutes to treat critical blood loss | Health Technology |
American Association of Blood Banks
American Association of Blood Banks Miscellaneous Commercial ServicesCommercial Services Operates an association of blood and biotherapies | Commercial Services |
Hemanext, Inc.
Hemanext, Inc. Medical SpecialtiesHealth Technology Develops anaerobic storage system that minimizes oxidative damage to red blood cells | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Choisissez Zonebourse 
